No sample was returned for evaluation.
Manufacturing review of the referenced lot number and respective device history record was conducted on 8sep2021, showing that all units were quality released on 13apr2021 having met all internal qc acceptance requirements.
There was one non-conformance associated with the manufacturing lot during the final packaging which was addressed through a nonconforming materials report.
It was resolved and was unrelated to the reported adverse event.
Sterile subassembly lot m20m1337 (prt-20679-09) was also reviewed for potential issues impacting the quality of this product.
This subassembly lot was released to component inventory on 30nov2020 having met all quality requirements including product sterility testing following eo sterilization, as well as internal bioburden and product pyrogen (lal) testing requirements.
In lieu of a request for the oem supplier for a dhr review of the ecm material lots, it is noted that aziyo processes the non-sterile envelope materials by cutting, suturing, packaging, and sterilizing.
It is also noted that per the instructions for use (ifu - art-20662c) provided with the finished cangaroo envelope device, "inflammation" is listed as a potential complication associated with this procedure and device usage.
|